Investing.com -- Eli Lilly and Company (NYSE: LLY) CEO David Ricks spoke to the BBC about the long-term effects of the Trump administration’s sweeping tariffs on imports, in the first comments from a ...
Indian pharmaceutical stocks fell 4.4% on Friday, wiping out gains from the previous session, after U.S. President Donald ...
The Chief Executive of Eli Lilly has told the BBC that he is doubtful tariffs could bring manufacturing jobs to the US whilst ...
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces the appointment of Anne Whitaker as ...
Drugmaker stocks gained a temporary reprieve on Thursday as U.S. President Donald Trump spared pharmaceutical products from ...
Liberation Day did not deliver punitive tariffs on the pharmaceutical sector - but the reprieve could be short lived.
Corporation announced that it has received a letter of intent from one of the world’s leading pharmaceutical makers to provide ...
We recently published a list of 10 Best Healthcare Stocks to Buy According to Billionaires. In this article, we are going to ...
Indianapolis Zoo and Eli Lilly are part of a push to move medical industry away from using horseshoe crab blood and towards ...
While Novartis and Bayer got there first, AstraZeneca, Bristol Myers Squibb and Eli Lilly are all vying to bring their ...
Dr. Jitendra Singh, a renowned endocrinologist himself, emphasized the unique metabolic challenges faced by India due to its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback